Validation of the albumin‐bilirubin grade‐based integrated model as a predictor for sorafenib‐failed hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|2|321-330

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.2, 2018-02, pp. : 321-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade

By  

Oncology, Vol. 91, Iss. 3, 2016-07 ,pp. : 153-161

Karger

Access to resources Recommend Favorite

A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E61-E67

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 6-13

Karger

Access to resources Recommend Favorite

Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 10, 2015-10 ,pp. : 1250-1258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor

By  

LIVER TRANSPLANTATION, Vol. 1527-6465, Iss. 10, 2015-10 ,pp. : 1250-1258

John Wiley & Sons Inc

Access to resources Recommend Favorite